Search
Artemisinin
go.drugbank.com/drugs/DB13132InvestigationalArtemisinin has been used in trials studying the treatment of Schizophrenia, Malaria, Falciparum, and Plasmodium Falciparum.
Categories: Artemisinin and derivatives, artemisinin and piperaquineDDP733
go.drugbank.com/drugs/DB05049InvestigationalDDP733 is an oral prokinetic drug which Dynogen is developing as a treatment for both Irritable Bowel Syndrome with constipation (IBS-c) and nocturnal gastroesophageal reflux disease (NGERD).
Col-118
go.drugbank.com/drugs/DB05778InvestigationalCol-118 is a unique formulation and presentation of Brimonidine, which is a selective alpha-2 adrenergic receptor agonist. … COL-118, a topical compound based on the SansRosa technology, for the treatment of redness associated with rosacea and other skin disorders.
TRV-120027
go.drugbank.com/drugs/DB12199InvestigationalTRV120027 has been used in trials studying the treatment of Heart Failure and Kidney Disease.
Categories: Amino Acids, Peptides, and ProteinsMiravirsen
go.drugbank.com/drugs/DB12851InvestigationalMiravirsen has been investigated for the treatment of Hepatitis C and Hepatitis C, Chronic.
Categories: Nucleic Acids, Nucleotides, and NucleosidesDulanermin
go.drugbank.com/drugs/DB12349InvestigationalDulanermin has been used in trials studying the treatment of Colorectal Cancer, Non-Hodgkin's Lymphoma, and Metastatic Colorectal Cancer.
Categories: Amino Acids, Peptides, and Proteins, Intercellular Signaling Peptides and ProteinsAMG 108
go.drugbank.com/drugs/DB05545InvestigationalAMG 108 was investigated for use as an antirheumatic agent.
Categories: Amino Acids, Peptides, and ProteinsBordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)
go.drugbank.com/drugs/DB10991ApprovedInvestigationalBordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) is a vaccine that is used in the prophylaxis of Pertussis (whooping cough), which is caused by a small Gram-negative coccobacillus
Vopratelimab
go.drugbank.com/drugs/DB15378InvestigationalVopratelimab is under investigation in clinical trial NCT02904226 (JTX-2011 Alone and in Combination With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors).
Categories: Amino Acids, Peptides, and Proteins